Mapping Pathways is a multi-national project to develop and nurture a research-driven, community-led global understanding of the emerging evidence base around the adoption of antiretroviral-based prevention strategies to end the HIV/AIDS epidemic. The evidence base is more than results from clinical trials - it must include stakeholder and community perspectives as well.

16 July 2012

NEJM Publishes Papers on PrEP

Last week, The New England Journal of Medicine published online papers on the Partners ("Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women"), FEM-PrEP ("Preexposure Prophylaxis for HIV Infection among African Women") and TDF2 ("Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana") studies.

There was also an editorial "Preexposure prophylaxis for HIV - Where Do We Go From Here," and a look at some interesting case vignetttes - would YOU prescribe PrEP in these circumstances?.

These are great resources, hope you check them out.

[Content that is linked from other sources is for informational purposes and should not construe a Mapping Pathways position. Please look for us on Facebook here and you can follow us on Twitter @mappingpathways as well.]

No comments:

Post a Comment